Search results
Results from the WOW.Com Content Network
γ-Hydroxybutyric acid, also known as gamma-hydroxybutyric acid, GHB, or 4-hydroxybutanoic acid, is a naturally occurring neurotransmitter and a depressant drug.It is a precursor to GABA, glutamate, and glycine in certain brain areas.
This is where the user has become tolerant to the effects of the drug, increasing the dosage and frequency of dosage simply to avoid withdrawal symptoms. For those users who do report withdrawal symptoms upon quitting the use of GHB or GBL, symptoms seem to depend on the dosage and the length of time the drug was used.
Sodium oxybate is the sodium salt of γ-hydroxybutyric acid (GHB). The clinical trials for narcolepsy were conducted just as abuse of GHB as a club drug and date rape drug became a matter of public concern.
Gamma-hydroxybutyrate (GHB) is a central nervous system depressant. It has no odor and tastes salty, [30] but the taste can be masked when mixed in a drink. [31] GHB is used recreationally to stimulate euphoria, to increase sociability, to promote libido and lower inhibitions. [32] It is sold under names such as Rufies, Liquid E and Liquid X.
Brendan Paul, 25, was originally accused of transporting a wide array of drugs for Combs, including GHB, the common date-rape drug allegedly used against his victims. He was arrested at a Miami ...
The function of the GHB receptor appears to be quite different from that of the GABA B receptor. It shares no sequence homology with GABA B, and administration of mixed GHB/GABA B receptor agonists, along with a selective GABA B antagonist or selective agonists for the GHB receptor which are not agonists at GABA B, do not produce a sedative effect, instead causing a stimulant effect, followed ...
GHB, or gamma-hydroxybutyric acid, is sometimes known as a "date rape drug," per the Drug Enforcement Administration. Combs then allegedly instructed the boy to move closer to him, after which he ...
Jazz Pharmaceuticals (JAZZ) shares slumped more than 5% in premarket trading Monday after the Palo Alto, Calif.-based company announced that, as expected, the Food and Drug Administration had ...